Moscow, Sep 14 (UNI) Russia's Ministry of Health has authorised clinical trials of a modified version of Russia's Sputnik V vaccine against COVID-19, the data from the registry of approved clinical trials has shown.
"The goal of the clinical study: to evaluate the safety, reactogenicity and immunogenicity of the Gam-COVID-Vac vector vaccine [Sputnik V] for the prevention of coronavirus infection caused by the SARS-CoV-2 virus with a modified antigenic profile in adult volunteers," the line in the registry has shown.
The clinical study will be completed on December 31, 2024. As many as 100 volunteers are expected to participate in the trials, according to the registry.